Circadian rest-activity rhythm is altered in Parkinson's disease patients with hallucinations

Movement Disorders

Volumn 23, Issue 8, 2008, Pages 1137-1145

  Whitehead, Daisy L ^a   Davies, Ann D M ^b,c   Playfer, Jeremy R ^d   Turnbull, Christopher J ^e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c MERSEY CARE NHS TRUST   (United Kingdom)

^d ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^e ARROWE PARK HOSPITAL   (United Kingdom)

Author keywords

Actigraphy; Circadian; Hallucinations; Parkinson's disease; Rest activity rhythm

Indexed keywords

APOMORPHINE; CABERGOLINE; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; HYPNOTIC AGENT; LEVODOPA; LISURIDE; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; SEDATIVE AGENT;

ACTIMETRY; ADULT; AGED; ARTICLE; BRAIN STEM; CIRCADIAN RHYTHM; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG FORMULATION; DYSKINESIA; FEMALE; HALLUCINATION; HUMAN; HYPOTHALAMUS; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; SLEEP WAKING CYCLE; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; CIRCADIAN RHYTHM; DOPAMINE AGONISTS; FEMALE; HALLUCINATIONS; HUMANS; MALE; MIDDLE AGED; MONITORING, AMBULATORY; MOTOR ACTIVITY; PARKINSON DISEASE; REFERENCE VALUES; REST; SLEEP DISORDERS, CIRCADIAN RHYTHM;

EID: 52649165557     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22057     Document Type: Article

References (39)

1. Chaudhuri KR, Martinez-Martin P, Schapira AHV, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006;21:916-923.
2. Garcia-Borreguero D, Larrosa O, Bravo M. Parkinson's disease and sleep. Sleep Med Rev 2003;7:115-129.
3. Diederich NJ, Vaillant M, Mancuso G, Lyen P, Tiete J. Progressive sleep 'destructuring' in Parkinson's disease. A polysomngraphic study in 46 patients. Sleep Med 2005;6:313-318.
4. Rye DB, Bliwise DL, Dihenia B, Gurecki P. Daytime sleepiness in Parkinson's disease. J Sleep Res 2000;9:63-69.
5. Arnulf I, Bonnet AM, Damier P, et al. Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis. Neurology 2000;55:281-288.
6. Stevens S, Comella CL, Stepanski EJ. Daytime sleepiness and alertness in patients with Parkinson disease. Sleep 2004;27:967-972.
7. van Someren EJW, Hagebeuk EEO, Lijzenga C, et al. Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol Psychiatry 1996;40:259-270.
8. Swaab DF. Biological rhythms in health and disease: the suprachiasmatic nucleus and the autonomic nervous system. In: Appenzeller O, editor. The autonomic nervous system, Part I: Normal functions. Amsterdam: Elsevier Science; 1999, p 467-521.
9. Hatfield CF, Herbert J, van Someren EJW, Hodges JR, Hastings MH. Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. Brain 2004;127:1061-1074.
10. Hoekert M, Riemersma-van der Lek R, Swaab DF, Kaufer D, van Someren EJW. Comparison between informant-observed and actigraphic assessments of sleep-wake rhythm disturbances in demented residents of homes for the elderly. Am J Geriatr Psychiatry 2006;14:104-111.
11. Carvalho-Bos SS, Riemersma-van der Lek R, Waterhouse J, Reilly T, van Someren EJW. Strong association of the rest-activity rhythm with well-being in demented elderly women. Am J Geriatr Psychiatry 2007;15:92-100.
12. Stopa EG, Volicer L, Kuo-Leblanc V, et al. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J Neuropathol Exp Neurol 1999;58:29-39.
13. Harper DG, Volicer L, Stopa EG, McKee AC, Nitta M, Satlin A. Disturbance of endogenous circadian rhythm in aging and Alzheimer disease. Am J Geriatr Psychiatry 2005;13:359-368.
14. Martin J, Marler M, Shochat T, Ancoli-Israel S. Circadian rhythms of agitation in institutionalized patients with Alzheimer's disease. Chronobiol Int 2000;17:406-418.
15. Bliwise DL, Carroll JS, Lee KA, Nekich JC, Dement WC. Sleep and sundowning in nursing-home patients with dementia. Psychiatry Res 1993;48:277-292.
16. Meeks TW, Ropacki SA, Jeste DV. The neurobiology of neuropsychiatric syndromes in dementia. Curr Opin Psychiatry 2006; 19:581-586.
17. Border R, Devos D, Brique S, et al. Study of circadian melatonin secretion pattern at different stages of Parkinson's disease. Clin Neuropharmacol 2003;26:65-72.
18. Pierangeli G, Provini F, Maltoni P, et al. Nocturnal body core temperature falls in Parkinson's disease but not in multiple-system atrophy. Mov Disord 2001;16:226-232.
19. Pursiainen V, Haapaniemi TH, Korpelainen JT, Huikuri HV, Sotaniemi KA, Myllyla VV, Circadian heart rate variability in Parkinson's disease. J Neurol 2002;249:1535-1540.
20. Bruguerolle B, Simon N. Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function. Clin Neuropharmacol 2002;25:194-201.
21. Hartmann A, Veldhuis JD, Deuschle M, Standhardt H, Heuser I. Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol Aging 1997;18:285-289.
22. Van Hilten B, Hoff J, Middelkoop H, et al. Sleep disruption in Parkinson's disease; assessment by continuous activity monitoring. Arch Neurol 1994;51:922-928.
23. Comella CL, Morrissey M, Janko K. Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy. Neurology 2005;64:1450-1451.
24. Katayama S. Actigraph analysis of diurnal motor fluctuations during dopamine agonist therapy. Eur Neurol 2001;46:11-17.
25. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical-diagnosis of idiopathic Parkinson's-disease - a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55: 181-184.
26. Folstein MF, Folstein SE, Mchugh PR. Mini-mental state - practical method for grading cognitive state of patients for clinician. J Psychiatr Res 1975;12:189-198.
27. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
28. Fahn S, Elton RL, and members of the UPDRS Development Commitee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease, Vol. 2. Florham Park, NJ: Macmillan Health Care Information; 1997. p 153-163.
29. Wenzelburger R, Zhang BR, Pohle S, et al. Force overflow and levodopa-induced dyskinesias in Parkinson's disease. Brain 2002; 125;871-879.
30. van Someren EJW, Swaab DF, Colenda CC, Cohen W, Mccall WV, Rosenquist PB. Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol Int 1999;16:505-518.
31. Huang Y, Liu R, Wang Q, van Someren EJW, Xu H, Zhou J. Age-associated difference in circadian sleep-wake and rest-activity rhythms. Physiol Behav 2002-176:597-603.
32. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004;318:121-134.
33. Fronczek R, Overeem S, Lee S, et al. Hypocretin (orexin) loss in Parkinson's disease. Brain 2007;130:1577-1585.
34. Saper CB. Cano G, Scammell TE. Homeostatic, circadian, and emotional regulation of sleep. J Comp Neurol 2005;493:92-98.
35. Manni R, Pacchetti C, Terzaghi M, Sartori I, Zangaglia R, Nappi G. Sleep-wake cycle and visual hallucinations in Parkinson's disease. Mov Disord 2002;17(Suppl 5):368.
36. Dowling GA, Mastick J, Colling E, Julie JH, Singer CM, Aminoff MJ. Melatonin for sleep disturbances in Parkinson's disease. Sleep Med 2005;6:459-466.
37. Siegel JM. Hypocretin administration as a treatment for human narcolepsy. Sleep 2003;26:932-933.
38. Paus S, Schmitz-Hubsch T, Wullner U, Vogel A, Klockgether T, Abele M. Bright light therapy in Parkinson's disease: a pilot study. Mov Dis 2007;22:1495-1498.
39. Karlsen KH, Larsen JP, Tandberg E, Maeland JG. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatr 1999; 66:431-435.